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Accepted 26 January 2021In 2012, WHO/FAO ranked 24 foodborne parasites (FBP) using multicriteria decision analysis
(MCDA) to provide risk assessors with a basis for prioritising control of highly ranked FBP on
the global level. One conclusion was that ranking may differ substantially per region. In
Europe, the same methodology was used to rank FBP of relevance for Europe. Of the 24 FBP,
the top-five prioritised FBP were identified for Europe as Echinococcus multilocularis, Toxo-
plasma gondii, Trichinella spiralis, E. granulosus, and Cryptosporidium spp., all of which are zoo-
notic. The objective of the present study was to provide an overview of surveillance and
reporting systems in Europe for these top five prioritised FBP in the human and animal popu-
lations, to identify gaps, and give recommendations for improvement. Information on the sur-
veillance systems was collected from 35 European countries and analysed according to the five
different regions. For most FBP, human surveillance is passive in most countries and regions in
Europe and notification differs between countries and regions. Adequate surveillance
programmes for these FBP are lacking, except for T. spiralis, which is notifiable in 34 countries
with active surveillance in susceptible animals under EU directive. Although human and animal
surveillance data are available for the five prioritised FBP, we identified a lack of consistency in
surveillance and reporting requirements between national experts and European bodies. Rec-
ommendations for improved surveillance systems are discussed.
© 2021 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.
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Foodborne parasites (FBP) have long been neglected, mainly due to their complex life cycles, various transmission routes,
and often chronic health effects (Robertson, 2018). Using risk-ranking methods such as multicriteria decision analyses
(MCDA) and disease-burden estimations (Devleesschauwer et al., 2017), FBP have been increasingly recognised as being re-
sponsible for considerable disease burdens globally (Havelaar et al., 2015). In 2012, FAO/WHO ranked 24 FBP according to
MCDA, to provide risk assessors with a basis for prioritising control of highly ranked FBP (Food and Agriculture
Organization of the United Nations/World Health Organization (FAO/WHO), 2014). Taenia solium, a cestode, ranked highest
of the 24 FBP on the global level using MCDA. In addition, the WHO Foodborne Disease Burden Epidemiology Reference
Group (FERG) estimated the global disease burden using the disability-adjusted life years (DALYs) metric for 31 foodborne
microbiological and chemical hazards. Among FBP, T. solium was found to be responsible for the greatest burden of DALYs
(Torgerson et al., 2015) indicating that both risk-ranking methods identified the same FBP on the global level as most impor-
tant. One conclusion of the FAO/WHO global-perspective exercise was that ranking may differ substantially by region. During
COST Action FA1403, A European Network for Foodborne Parasites (Euro-FBP), an approach similar to that of FAO/WHO was
used to determine and rank the most important FBP in Europe (Bouwknegt et al., 2018). Based on MCDA, Echinococcus
multilocularis was the highest-ranked FBP in Europe, followed by, in order, Toxoplasma gondii, Trichinella spiralis,
E. granulosus, and Cryptosporidium spp. (Bouwknegt et al., 2018).
The cestode E. multilocularis, which ranked the highest in Europe, is the aetiological agent of alveolar echinococcosis (AE), a
severe zoonotic disease with a substantial impact on human health, and among the most important emerging parasitic dis-
eases in Europe (Hegglin and Deplazes, 2013; European Food Safety Agency Panel on Biological Hazards (BIOHAZ) et al.,
2018). Humans become infected through ingestion of the tapeworm eggs shed by the definitive host, mainly foxes in
Europe. A source-attribution systematic review and meta-analysis indicated that both drinking water and food, as well as di-
rect contact with infected hosts, were relevant transmission vehicles (Torgerson et al., 2020). AE is commonly associated with
a long incubation period that may last for more than ten years (Conraths et al., 2017). The second-highest ranked parasite in
Europe, the zoonotic protozoan T. gondii, causes congenital and acquired toxoplasmosis. Humans acquire T. gondii infection
through consumption of raw/undercooked meat containing viable tissue cysts, or through ingestion of oocysts in soil, water
or as contaminants of fresh produce (European Food Safety Agency Panel on Biological Hazards (BIOHAZ) et al., 2018).
T. spiralis, the third-ranked FBP, is a zoonotic nematode causing trichinellosis when raw or undercooked meat from an infected
animal is consumed. Although the disease burden of trichinellosis is considered of minor importance at the global level
(Havelaar et al., 2015) and ranked 7th on the global scale using MCDA, in Europe the situation is different. Almost half of
all reported cases worldwide are reported in Europe (Devleesschauwer et al., 2015) where domestic pigs not raised under con-
trolled housing conditions and wild boar are the main sources of human infections. T. spiralis (and other Trichinella species) are
the only FBP of these top-five for which there is mandatory-targeted surveillance in susceptible meat-producing animals that
are placed on the EU market during meat inspection in Europe (European Commission, 2015). An exemption has recently been
implemented for fattening pigs raised under controlled housing conditions (European Commission, 2015). Tapeworms of the
E. granulosus complex cause cystic echinococcosis (CE) in humans through ingestion of the eggs shed by the definitive host,
mainly dogs. Since the incubation period is long and can range from five to fifteen years, risk factors are difficult to identify
although contaminated raw produce or water are considered the transmission pathway (Possenti et al., 2016). This zoonotic
fourth-ranked FBP can cause economic losses in animals and high morbidity in people (Torgerson et al., 2015; European
Food Safety Agency Panel on Biological Hazards (BIOHAZ) et al., 2018). CE has a lower disease burden than AE due to lower
mortality, but exerts a substantial burden in southern Europe (Tamarozzi et al., 2018). The fifth-ranked parasite in Europe
was the protozoan Cryptosporidium spp. At least 30 species of Cryptosporidium have been described; some are host specific,
whereas others can infect various hosts. Cryptosporidium parvum (zoonotic) and C. hominis are the species most commonly as-
sociated with human infection in Europe, after oral uptake of oocysts shed by infected hosts. The main risk factors for
C. hominis are linked to contact with young children, people with diarrhoea or contamination of water by human waste or
wastewater. Although C. parvum can also be spread between people, the main risk factors are linked to contact with farm an-
imals, especially young stock (e.g., at petting farms), or consumption of water or food contaminated by their faeces (Cacciò and
Chalmers, 2016). Cryptosporidiosis causes self-limiting diarrhoea in immunocompetent hosts (European Food Safety Agency
Panel on Biological Hazards (BIOHAZ) et al., 2018; Cacciò and Chalmers, 2016).
The European One Health zoonoses report, published annually by European Food Safety Authority in Parma (EFSA) and
European Center for Disases Control in Stockholm (ECDC), describes data on zoonoses, zoonotic agents, antimicrobial resistance
and food-borne outbreaks (FBO) under the Zoonoses Directive 2003/99/EC (Community, 2003). Among the top-five prioritised
FBP, it is mandatory to report data on trichinellosis and echinococcosis; for cryptosporidiosis and toxoplasmosis, reporting is
based on national considerations (European Food Safety Authority and European Centre for Disease Prevention and Control,
2018). The accuracy, reliability, and usefulness of these data depend on systematic and uniform surveillance and reporting across
Europe. However, we know that this is not always the case.
Surveillance systems may be implemented for different purposes such as early warning and detection, clinical case finding, to
estimate the magnitude or occurrence of infection by prevalence or incidence, or to determine freedom of disease. In animal pop-
ulations, surveillance could also serve to prevent human infections. One example is mandatory slaughterhouse surveillance for
Trichinella, where positive animals are removed from the food chain, thereby preventing human infections. Clinical case reporting2
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pathogen in human or animal populations are conducted following a specified sampling plan. Risk-based surveillance and surveil-
lance systems to determine freedom of disease are increasingly being used in veterinary medicine (Stärk et al., 2016). Risk-based
surveillance and control principles for FBP have recently been described by Alban et al. (2020), whereas the control of Trichinella
spp. in Suidae in Europe, has been regulated at the EU level. The advantage of risk-based surveillance is increased cost effective-
ness of the surveillance (European Commission, 2015).
The present study provides an overview of the different surveillance and reporting systems in Europe for the top-five
prioritised FBP in human and animal populations, identifies gaps, and suggests recommendations for improvement.
2. Materials and methods
The survey was conducted in the same five European regions as reported for prioritising FBP in Europe: Northern, Western,
Eastern, Southeastern, and Southwestern as previously described (Bouwknegt et al., 2018). Regional coordinators of the
Euro-FBP network identified and contacted experts or agencies in each country of their region, sending them a questionnaire
for completion and a glossary document with explanations. The questionnaire requested information about disease notification
and surveillance systems for humans and animals during the previous five years (2014–2018), the populations (for humans)
under surveillance, reporting sources, and case definitions as described in EU decision 2018/945 (Commission Implementing
Decision (EU), 2018). Data of the various countries per parasite were combined in a common Excel database and afterwards
analysed per region. Results from the different regions were combined per parasite and discussed in a common meeting of all re-
gional coordinators. An additional online questionnaire was subsequently used to address gaps and inconsistencies identified at
the meeting (Supplementary file). We did not wish to include project-based surveillance, as this may be non-systematic and
short-term, unless conducted according to governmental requirements (e.g., E. multilocularis in wildlife to document freedom
from infection).
The information collected used the following pre-agreed definitions and criteria:
● Notifiable: by law of that country.
● Passive surveillance: gathering data from clinical or laboratory diagnosed cases of infection.
● For humans, notifiable diseases are based on passive surveillance of the whole population; for non-notifiable diseases, this
can be for a restricted population (e.g., pregnant women).
● For animals, only for infections that cause clinical symptoms, such as E. multilocularis infections in dogs causing alveolar
echinococcosis; T. gondii infections in pregnant sheep, Cryptosporidium infection in ruminants.
● Active surveillance: analyses for a particular pathogen in human or animal populations follow a statistical or probability-based
sampling plan. This is important in surveillance of diseases in which subclinical cases/carriers predominate. Active surveillance
in humans may be population-based for, e.g., government records. Data from meat inspection of slaughtered animals for food
production in the abattoir is defined as active surveillance in this study. Population-based surveillance can also include mon-
itoring for justifying derogation from regulations, such as compulsory treatment of imported dogs into countries with proven
absence of E. multilocularis in wildlife (Commission Delegated Regulation (EU), 2018; European Food Safety Authority and
European Centre for Disease Prevention and Control, 2019).
The various active and passive surveillance systems in the different countries were not evaluated for their effectiveness, and no
data on this aspect were requested in the questionnaire.
3. Results
3.1. General overview
In total, 35 countries including EU Member States (MS) and non-MS in five European regions were included in the study.
• In Northern (N) Europe: Denmark (DK), Finland (FI), Iceland (ICE), Norway (NO), Sweden (SWE).
• In Western (W) Europe: Austria (AU), Belgium (BE), Germany (DE), France (FR), Liechtenstein (LI), Republic of Ireland (IE), The
Netherlands (NL), Switzerland (CH), United Kingdom (UK).
• In Eastern (E) Europe: Czech Republic (CZ), Estonia (EE), Hungary (HU), Latvia (LV), Poland (PL), Romania (RO), Slovakia (SK).
• In Southwestern (SW) Europe: Italy (IT), Portugal (PT), Spain (ES).
• In Southeastern (SE) Europe: Albania (AL), Bosnia and Herzegovina (BH); Bulgaria (BG); Croatia (HR), Cyprus (CY), Greece (GR),
Montenegro (ME), North Macedonia (MK), Serbia (RS), Slovenia (SL), Turkey (TR).
For many countries, information was obtained from public health and animal health institutes and food-safety agencies. The
different surveillance systems in humans and animals are combined by region (Tables 1-5), and also described by parasite for
all regions.
Active surveillance during meat inspection was described in EU Regulation 854/2004 and, since 2019, replaced by EU Regula-
tion 627/2019 (European Regulation (EC), 2004; Commission Regulation (EU), 2019) for the MS. In the EU Regulation, practical
arrangements for official control for cysticercosis during post-mortem inspection caused by Taenia saginata in domestic bovine an-
imals and by T. solium for Suidae and for Trichinella spp. in susceptible slaughter animals are included. Risk-based surveillance has3
Table 1
Surveillance systems in humans and animals in Northern Europe. Countries included in the region – Denmark (DK), Finland (FI), Iceland (ICE), Norway (NO), Sweden
(SWE).
















None All All DK, FI, ICE,
NOd
Red foxes and slaughtered
animalse
Allg
Toxoplasmosis/Toxoplasma gondii FI, ICEb ICE DK, FI, ICE FIc; ICE None None FI, ICEg


















None All None DK Cervids None
a DK is currently developing its notification system;
b FI, ICE report only congenital toxoplasmosis;
c In FI T. gondii is notifiable in swine, sheep, goat, dog, cat and ferret;
d FI andmainlandNO confirmed the free status for E.multilocularis in the context of Regulation (EU) No. 1152/2013 (EFSA, 2019); in DK active surveillance is present
in cervids for Cryptosporidium spp.;
e E.multilocularis and E. granulosus– slaughter animals undermeat inspection former EUDirective 854/2004 since 13/12/2019 replaced by EUdirective 2019/627 and
governmental monitoring programmes for red foxes; only in ICE dogs are also under active surveillance for E. granulosus;
f Trichinella spp. –mandatory surveillance/control of slaughtered pigs, solipeds, wild boar and susceptible animals intended for human consumption according to EU
regulation 2015/1375, in SWE also in bears.
g Passive surveillance for alveolar echinococcosis (E. multilocularis) in dogs and cats, toxoplasmosis (T. gondii) in sheep; E. granulosus shedding in canids. Reporting
uncertain.
Table 2
Surveillance systems in humans and animals in Western Europe. Countries included in the region – Austria (AU); Belgium (BE); France (FR); Germany (DE);
Liechtenstein (LI); Republic of Ireland (IE); The Netherlands (NL); Switzerland (CH); United Kingdom (UK).
















None All BE, CH, DE,
IE, NL, UK
AU, BE, CH, DE,
IE, NL, UKc
Red foxes and slaughtered
animalsd
BE, CH, FR, LI,
NLf








BE, DE, FR, NL Livestock BE, CH, DE, IE,
LI, NL, UKf




None All All All Slaughtered pigs, solipeds,






None All All All Slaughtered animalsd CH, DE, NLf
Cryptosporidiosis/Cryptosporidium
spp.
DE, IE, UK NLg All CH None None CH, IE, NL, UKf
a Congenital toxoplasmosis;
b For toxoplasmosis in AU, BE, DE, FR – screening in pregnant women; NL and DE – seroprevalence.
c IE and UK confirm the free status for E. multilocularis in the context of Regulation (EU) No. 1152/2011 (EFSA 2019), seroprevalence studies in BE, DE, FR and NL
reported;
d E. multilocularis and E. granulosus – slaughter animals undermeat inspection former EUDirective 854/2004 since 13/12/2019 replaced by EU directive 2017/627 for
cysticercosis; and governmental monitoring programmes for red foxes.
e Trichinella spp. –mandatory surveillance/control of slaughtered pigs, solipeds, wild boar and susceptible animals intended for human consumption according to EU
regulation 2015/1375; In IE risk based active surveillance in red foxes.
f Passive surveillance for alveolar echinococcosis (E. multilocularis) in dogs and cats, toxoplasmosis (T. gondii) in sheep; E. granulosus shedding in canids, Crypto-
sporidiosis (Cryptosporidium spp) in ruminants. Reporting uncertain.
g Laboratory surveillance.
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2015). For Echinococcus spp. no additional arrangements are included. As Echinococcus spp. cysts are identifiable during meat in-
spection, both E. granulosus and E. multilocularis lesions are included as active surveillance in Tables 1-5 for slaughter animals.
However, E. multilocularis cysts are seldom present in slaughter animals.
All countries reported that they follow case definitions of the parasitic diseases under survey, according to EU decision 945/
2018 in all regions (Commission Implementing Decision (EU), 2018).4
Table 3
Surveillance systems in humans and animals in Eastern Europe. Countries included in the region – Czech Republic (CZ); Estonia (EE), Hungary (HU); Latvia (LV); Poland
(PL); Romania (RO), Slovakia (SK).














All PL All All CZ; PL Slaughtered animals; red foxesc LV; PL; RO;
SKf
Toxoplasmosis/Toxoplasma gondii Alla CZ, PL, HU,
SK
All PL, LV PLb Cattle, pigsb LV; PL; RO;
SKf
Trichinellosis/T. spiralis and other
Trichinella spp.
All None All All All Slaughtered pigs, solipeds and




All PL All All CZ; HU; LV;
PL; SK








None All None PLe Cattlee CZ; LV; PL;
RO; SKf
a Mainly congenital toxoplasmosis is notifiable, in CZ only acquired toxoplasmosis is notifiable, in HU, EE, SK – both congenital and acquired toxoplasmosis is
notifiable;
b In PL seroprevalence studies in cattle and pigs;
c E. multilocularis and E. granulosus – slaughter animals under meat inspection former EU Directive 854/2004 since 13/12/2019 replaced by EU directive 2019/627 in
CZ red foxes intended for rabies examination acrosswhole country yearly, inHU1%of red fox population every fourth year, in PL red foxes and dogswithin governmen-
tal monitoring program;
d Trichinella spp. –mandatory surveillance/control of slaughtered pigs, solipeds, wild boar and susceptible animals intended for human consumption according to EU
regulation 2015/1375, in CZ red foxes intended for rabies examination across whole country yearly, in HU 1% of red fox population every fourth year;
e Cryptosporidium spp. – in PL slaughtered animals under governmental monitoring program.
f Passive surveillance for alveolar echinococcosis (E. multilocularis) in dogs and cats; toxoplasmosis (T. gondii) in sheep; E. granulosus shedding in canids, crypto-
sporidiosis(Cryptosporidium spp.) in ruminants. Reporting uncertain.
Table 4
Surveillance systems in humans and animals in Southwestern Europe. Countries included in the region – Italy (IT); Portugal (PT); Spain (ES).













All None All All All Slaughtered animalsc None
Toxoplasmosis/Toxoplasma gondii Alla Allb All None None None ESe
Trichinellosis/T. spiralis and other
Trichinella spp.





All None All PT All Slaughtered animalsc ES, ITe
Cryptosporidiosis/Cryptosporidium
spp.
ES; PT None All None None None None
a Congenital toxoplasmosis; in IT, toxoplasmosis is notifiable without specifying the form of infection (congenital or acquired);
b For congenital toxoplasmosis in IT, PT – screening in pregnant women; ES – only in some regions;
c E. multilocularis and E. granulosus – slaughtered animals under meat inspection former EU Directive 854/2004 since 13/12/2019 replaced by EU directive 2019/627
for cysticercosis.
d Trichinella spp. –mandatory surveillance/control of slaughtered pigs, solipeds, wild boar and susceptible animals intended for human consumption according to EU
regulation 2015/1375.
e Passive surveillance for alveolar echinococcosis (E. multilocularis) in dogs and cats; toxoplasmosis (T. gondii) in sheep; E. granulosus shedding in canids, Crypto-
sporidiosis (Cryptosporidium spp) in ruminants. Reporting uncertain.
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3.2.1. Echinococcus multilocularis and alveolar echinococcosis
Human cases of both alveolar echinococcosis (AE) caused by E. multilocularis and cystic echinococcosis (CE) caused by
E. granulosus sensu lato (s.l.) are reported as echinococcosis, as the EU case definition EU Decision 2018/945 (Commission
Implementing Decision (EU), 2018) does not distinguish between these diseases. Countries can, however, report cases into the
European Surveillance System database by species and, since 2019 (2018 data), by clinical presentation of the disease. ECDC
can use that data to differentiate between the two diseases. AU, CZ, DE, DK, FI, FR, HU, ICE, IE, NL, NO, SK and SWE declared
reporting AE separately from CE. Reporting of echinococcosis differs regionally, being notifiable in most countries, but not in
BE, CH, LI, NL and UK, where reporting is based on voluntary passive surveillance (European Food Safety Authority and
European Centre for Disease Prevention and Control, 2019). DK is developing its notification system. The disease is also not no-
tifiable in BH, BG and ME.5
Table 5
Surveillance systems in humans and animals in Southeastern Europe. Countries included in the region – Albania (AL); Bosnia and Herzegovina (BH); Bulgaria (BG);
Croatia (HR), Cyprus (CY), Greece (GR), North Macedonia (MK), Montenegro (ME), Serbia (RS), Slovenia (SL), Turkey (TR).
















None All AL, CY, GR,
MK, RS, SL
RS, SL Slaughtered animals red
foxesd
ALf
Toxoplasmosis/Toxoplasma gondii All except TRa BG, HR, SL,
RSb
Allc MK, RS, SL None None MK, RS, SLf











All None All All All except AL,
BG, MK





None All None None None MKf
a Congenital toxoplasmosis and for TR toxoplasmosis cases are registered but not compulsory to declare;
b For toxoplasmosis screening in pregnant women;
c In BG, CY, GR, TR passive surveillance only for congenital toxoplasmosis;
d E. multilocularis and E. granulosus – slaughter animals undermeat inspection former EUDirective 854/2004 since 13/12/2019 replaced by EU directive 2017/627 for
cysticercosis, red foxes by governmental monitoring programmes;
e Trichinella spp. –mandatory surveillance/control of slaughtered pigs, solipeds, wild boar and susceptible animals intended for human consumption according to EU
regulation 2015/1375;
f Passive surveillance for alveolar echinococcosis (E. multilocularis) in dogs and cats; toxoplasmosis (T. gondii) in sheep; E. granulosus shedding in canids, Crypto-
sporidiosis (Cryptosporidium spp) in ruminants. Reporting uncertain.
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and SW Europe, and six countries in SE Europe (AL, CY, GR, MK, RS, SL). In addition, E. multilocularis is notifiable in all countries in
E Europe; in HU (where all susceptible animals are examined for Echinococcus and Trichinella at slaughterhouses) parasite isolates
are sent with background data to the National Reference Laboratory (NRL) for Parasites for verification and species (genotype)
identification according to the Ministry of Agriculture. In several countries (AU, BE, CH, CZ, DE, IE, NL, PL, UK and all countries
in N Europe, except SWE), there is active surveillance of wildlife for E. multilocularis (mainly red foxes). Four countries (FI, IE,
UK, and mainland NO) have demonstrated the absence of E. multilocularis through implementation of an annual surveillance pro-
gramme required by the EU in accordance with Regulation (EU) No. 2018/772 (Commission Delegated Regulation (EU), 2018;
European Food Safety Authority and European Centre for Disease Prevention and Control, 2019).
Alveolar echinococcosis in dogs and cats will be reported during passive surveillance in BE, CH, FR, LI and NL but is very rare in
N and S Europe and therefore unclear if it will be reported in many regions.
Speciation of Echinococcus in animals is reported from CZ, DK, EE, FI, FR, HU, ICE, NL, NO, SK, and SWE.
3.2.2. Toxoplasma gondii and toxoplasmosis
In humans, the case definition is that of the EU (Commission Implementing Decision (EU), 2018) and sometimes regulated by
national legislation for acquired toxoplasmosis, as, for example, in HU and PT.
Congenital toxoplasmosis is notifiable in most European countries, except for AU, BE, CH, DK, NO, NL, and SWE, while both
acquired and congenital toxoplasmosis are notifiable in AL, BH, BG, CY, EE, ES, FI, GR, HR, HU, ICE, IE, ME, MK, LV, PL, PT, RO,
RS, SL and SK. In IT, toxoplasmosis is notifiable without specifying the form of infection (congenital or acquired), whereas ac-
quired toxoplasmosis is notifiable in CZ. Screening pregnant women is mandatory in AU, BE, FR, SK, HR, IT, PL, and SL, and,
since 2017, in RS, but is voluntary in BG, HU, and also in CZ and DE where screening is not covered by statutory health insurance
(European Centre for Disease Prevention and Control, 2019). In ES, screening is managed at the Autonomous Communities level.
In PT, screening it is not mandatory but highly recommended.
Passive surveillance of human clinical cases occurs in most countries, but whether these cases are reported is unclear. Clinical
cases are not reported in BE and NL. In some countries with passive surveillance (e.g., CZ, EE, HU, SK, SR) both hospitalised and
other patients with clinical signs are reported. In E Europe, active surveillance is carried out in PL in pregnant women, HIV-
positive patients, and organ donors/transplant recipients. Other countries in this region report passive surveillance, but in different
target groups, with mainly pregnant women and HIV-positive patients in CZ, EE, HU, LV, SK; preterm neonates and infants in HU
and SK; organ donors and transplant recipients in SK; and patients with clinical signs and hospitalised patients in PL, RO, SK.
Population-based serosurveillance studies have been reported from AU, BE, DE, ES, FR, ICE, NL, NO, PT and SWE (Hofhuis et al.,
2011; Findal et al., 2015; Evengård et al., 2001; Birgisdóttir et al., 2006). Underreporting in most countries seems likely due to the
lack of clear rules for reporting.
In animals, toxoplasmosis is notifiable in BE, CH, DE, FI, FR, ICE, IE, LI, LV, NL, MK, PL, RS and SL. Passive surveillance based on
clinical cases in N Europe occurs only in ICE and FI. In W Europe, infections (abortions in small ruminants) are notifiable in BE, IE,
and NL. Toxoplasmosis is reportable in livestock, companion animals, and zoo animals in CH, DE, and LI, but whether these cases
are reported is unclear. Passive surveillance is carried out in LV, PL, RO, and SK in all animal species with clinical signs and/or to6
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sive surveillance based on differential diagnosis in aborted small ruminants occurs in some Autonomous Communities in ES.
In some countries, active surveillance is carried out (serology and molecular methods) in slaughtered pigs, cattle, and sheep.
However, these programmes are not intended as control measures (European Food Safety Agency Panel on Biological Hazards
(BIOHAZ) et al., 2018).
3.2.3. Trichinella spiralis and trichinellosis
Notification of trichinellosis in humans is mandatory in all countries, except BE, FR, ME, TR and UK that have voluntary surveil-
lance. DK also does not report surveillance.
In all regions and almost all countries, Trichinella infection in animals is notifiable. Active surveillance is carried out in all coun-
tries during meat inspection according to EC regulation 1375/2015 (European Commission, 2015; Commission Regulation (EU),
2019). In IE, there is (active) risk-based surveillance in wildlife (red foxes); in PT there is an official surveillance plan for hunted
wild boar, and in ES and IT there is serological follow up in positive pig farms. In CZ, four red foxes are examined per 100 km2
annually, and active surveillance of wild boars and other wild animals (e.g. beavers, lynx, bear) used for human consumption
is reported.
3.2.4. Echinococcus granulosus and cystic echinococcosis
CE is notifiable in most countries in Europe, except BE, CH, DK, LI, NL, and UK, but there is no active surveillance. The case
definition of EU decision 2018/945 is used by those countries where CE is notifiable, but with no separate case definitions for
AE and CE and speciation of human cases as previously described.
In most countries, passive surveillance is based on reporting clinical cases. In ES, passive surveillance is conducted through the
“Red Nacional de Vigilancia Epidemiológica”. In IT, a register of CE that contains information from clinical cases has been extended
to the European Register of Cystic Echinococcosis (Rossi et al., 2016), to collect harmonised clinical data in the EU on a voluntary
basis.
In animals, E. granulosus is notifiable in most countries except IT and ES. Active surveillance is mandatory in all countries by
visual inspection of cysts in liver and lungs during meat inspection of ruminants, horses, and other susceptible animals, according
to European Regulation 2019/627 (Commission Regulation (EU), 2019). PCR confirmation of suspected cysts is reported by FR
and NL.
3.2.5. Cryptosporidium spp. and cryptosporidiosis
Human surveillance is passive in almost all countries and regions of Europe. There is wide variation both within and among
regions regarding notification of cases, with cryptosporidiosis being notifiable in most countries in N Europe except DK, three
countries in W Europe (DE, IE, UK), all countries in E Europe except PL, RO, and SK, all countries in SW Europe except IT, and
five countries (BG, HR, MK, ME, SL) in SE Europe. Most countries report all diagnosed patients with clinical signs, but SK reports
only hospitalised cases. Some countries (CZ, DK, FR, NL, NO, SWE) report that they identify and report specific Cryptosporidium
species. However, there are differences regarding Cryptosporidium speciation: in SWE cases are speciated at the public health
agency in the summer period and during outbreaks. In NO speciation is sometimes conducted, particularly during outbreak
investigations.
Animal surveillance for Cryptosporidium infection is passive (animals presenting with clinical signs) in all countries, apart from
active surveillance of cervids in DK and cattle in PL. Cryptosporidium infection in animals is not notifiable in any country except in
CH. Some countries (CZ, PL, FR, DK, NL) report specific Cryptosporidium species to EFSA.
4. Discussion
Here we provide an overview of different surveillance systems in Europe for the top-five prioritised FBP in human and animal
populations. These FBP, all of which are zoonotic, were prioritised using a similar approach as that used by WHO/FAO on the
global scale, and based on different, mostly public health-based, criteria (Bouwknegt et al., 2018). Among these five FBP, infections
caused by E. multilocularis, E. granulosus, and T. gondii tend not to cause acute clinical disease. For instance, most T. gondii infec-
tions are asymptomatic or only cause mild or unspecific symptoms; long-term sequelae, such as ocular toxoplasmosis, can occur
years later. CE and AE have long incubation periods, ranging from five to fifteen years, making it extremely difficult to study out-
break situations or determine source attribution for sporadic cases. For cryptosporidiosis, with a relatively short incubation period
(5–7 days), outbreaks can be more readily noticed and reported (European Food Safety Agency Panel on Biological Hazards
(BIOHAZ) et al., 2018). However, even for Cryptosporidium, reporting is a problem in many countries due to lack of routine diag-
nostics and speciation of human and animal cases.
In general, although human and animal surveillance data are available for all five FBP, the surveillance and reporting require-
ments vary among and within regions and countries, and among national experts and European bodies.
For instance, AE in humans, which ranked as the most important FBP (Bouwknegt et al., 2018), is notifiable in N, E, and SE
Europe, but in only four countries in W Europe. Moreover, echinococcosis speciation is not routinely conducted and, therefore,
when human cases are diagnosed, many countries report only “echinococcosis”, despite major differences in pathology, epidemi-
ology, and disease progress between CE and AE. Underreporting seems to be a major issue for CE in SE Europe, according to a
cross-sectional study (Tamarozzi et al., 2018), ultrasound screening of people in rural areas in Bulgaria, Romania and Turkey7
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confirmed echinococcosis cases reported to ECDC in 2017 and for 53% of the E. granulosus cases, Romania only for 2%. The inci-
dence data reported to ECDC differed from these values by a factor of 10 for Bulgaria and a factor 700 for Romania (Tamarozzi
et al., 2018). Similar results have been shown in Italy and Greece comparing research data and ECDC reports (European Food
Safety Authority and European Centre for Disease Prevention and Control, 2013; Brundu et al., 2014). In animals, Echinococcus
cysts (mainly E. granulosus) are not mentioned in EU regulation 2019/627 (Commission Regulation (EU), 2019) for the control
of animal products intended for human consumption, although the public health impact is huge in some regions in Europe. Con-
sequently, E. granulosus in slaughter animals is underreported in many countries due to the low sensitivity of meat inspection, the
lack of confirmation and PCR-based speciation of suspected lesions, and an absence of data registration systems. Due to the many
neglected CE cases in SW and SE Europe (Tamarozzi et al., 2018; Brundu et al., 2014), improved veterinary public health control
measures are particularly needed in these regions to prevent human exposure. Effectiveness of the improved control measures
can be monitored by active surveillance of the human population.
Active surveillance for E. multilocularis in wildlife (red foxes) occurs in many countries, but often only on voluntary basis, de-
spite EFSA recommending harmonised surveillance in wildlife (Boué et al., 2010). Thus, understanding the prevalence and spread
of this FBP is difficult. Furthermore, clinical cases in humans and infections in animals are not notifiable in many countries, and,
consequently, there is substantial underreporting of this emerging parasite in Europe (Conraths et al., 2017). In conclusion, sur-
veillance of both AE and CE in humans and animals is variable and fragmentary, with potential underreporting. In addition,
suspected human cases are not confirmed by PCR in many countries, and potential E. granulosus findings during meat inspection
are often not confirmed by PCR nor reported. Whereas E. multilocularis is a concern in N Europe according to the ranking as re-
ported by Bouwknegt et al. (2018), CE is considered to be a major neglected zoonosis in S Europe with significant economic losses
in the public health sector (Piseddu et al., 2017). Here the life cycle of E. granulosus s.s. continues, the disease burden is substan-
tial, and improved veterinary control is needed.
Mandatory and separate notification of E. granulosus and E. multilocularis infections in both humans and relevant animals is
strongly recommended in all countries, such that clearer insights into the extent of the problem are obtained and trends can
be analysed.
Congenital toxoplasmosis is notifiable in 29 of the 35 countries and pregnant women are screened in some countries; never-
theless, underreporting is still a major problem in many countries. Sero-surveillance studies have been conducted in DE, ICE, ES,
NL, IT, NO, PT, and SW. Data from these studies in NL has shown that toxoplasmosis has one of the highest disease burdens
among foodborne diseases (Havelaar et al., 2015). Although (sero)positivity is reported in slaughtered animals in most countries,
there is no mandatory control in Europe to prevent human infections via consumption of meat from infected livestock. This rein-
forces the need for risk-based surveillance systems in livestock. A social cost-benefit analysis of two interventions in NL showed
that freezing raw meat products would be beneficial (Suijkerbuijk et al., 2019).
As trichinellosis is notifiable in humans in most countries and there is mandatory control in animals, surveillance and
reporting of T. spiralis infections in humans and animals are the best of all five prioritised FBP. However, although serious clinical
cases are probably diagnosed, mild cases may be missed because active surveillance is lacking and outbreaks continue to occur,
mainly associated with meat products from pigs reared under non-controlled housing conditions and hunted wild boar. It has re-
cently been shown that pigs from controlled housing systems in Europe pose a negligible risk, and control should be focussed on
pigs reared outdoors and on wildlife intended for human consumption (Franssen et al., 2018). The EU directive 2015/1375 in-
cludes the possibility of this risk-based surveillance (European Commission, 2015). Such risk-based surveillance will not focus
on pigs in controlled housing with negligible risk, but on animal populations with a high risk for Trichinella, such as pigs reared
outdoors and wildlife intended for human consumption, such as wild boar.
Although there is general concordance across Europe regarding passive surveillance of both humans and animals for Cryptospo-
ridium, there are considerable differences in reporting, resulting in a skewed impression of the distribution of this parasite. Several
countries claimed to have voluntary notification, but it is unclear what such notification entails, and how the data are recorded or
to whom they are accessible. Information regarding speciation of Cryptosporidium was also variable among and within regions; in
some cases, it appeared that responsible agencies did not have a clear overview of whether speciation was conducted when cases
were diagnosed. This obviously affects the data quality. Although outbreaks of cryptosporidiosis are likely to be identified due to
the acute disease onset, underreporting of cases during outbreaks occurs, while many sporadic cases are probably not diagnosed.
Based on this data gathering, recommendations regarding surveillance and reporting of the top-five FBP in Europe may be de-
fined. Improved diagnosis and reporting of human CE and AE cases in Europe is needed with emphasis on the highly endemic
countries in southern Europe. Special attention should be given to species identification of the different echinococcus species
by molecular methods. In addition to human CE, also the reporting and the speciation of E. granulosus cysts mandatory during
animal slaughterhouse surveillance should be improved, and early warning and surveillance systems to determine the prevalence
need to be harmonised in wildlife for E. multilocularis throughout Europe. EFSA (2007) recommended a harmonised surveillance
scheme in wildlife with estimated prevalence sizes of targeted wildlife species, harmonised detection methods and targeted re-
gions for surveillance throughout Europe (Boué et al., 2010), but so far surveillance has often been project based and fragmented
in the different countries, making comparisons among countries extremely difficult. T. gondii causes is an important foodborne in-
fection that ranked high in Europe according to the MCDA methods (Bouwknegt et al., 2018) and DALY estimates for toxoplasmo-
sis (Havelaar et al., 2015). However, reporting of congenital toxoplasmosis is absent in many countries in Europe. More efforts are
needed to obtain better insight into congenital toxoplasmosis cases and the seroprevalence in Europe to improve estimation of the
disease burden and thus adequately prioritize the control measures to be taken. In animals, surveillance is underdeveloped in8
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based surveillance in meat producing animals can be based on risk assessment studies that are available for Italy and the
Netherlands (European Food Safety Agency Panel on Biological Hazards (BIOHAZ) et al., 2018) and could be used to prevent
human infections and thus reduce the disease burden in humans. Trichinellosis is the only FBP where reporting is mandatory
in most countries in humans, despite a low global disease burden (Torgerson et al., 2015). Therefore, how much effort is needed
to control this FBP in animal populations is debatable. However, half of the reported global human cases occur in Europe
(Devleesschauwer et al., 2015). Nowadays, a risk-based surveillance system can be implemented under EU reg. 2015/1375
(European Commission, 2015), which is also harmonised with guidelines for the Codex Alimentarius and the OIE (Alimentarius,
2015). Despite this, in almost all countries, all slaughtered pigs originating from controlled housing are tested. Therefore, risk-
based surveillance in animals should be given more priority to be implemented in Europe to improve cost effectiveness. Improve-
ment of human cryptosporidiosis reporting is needed, because only limited data are available about the presence and prevalence
of cryptosporidiosis in human populations. Moreover, harmonised detection methods will improve comparison of reporting be-
tween countries. Determination of whether human infections are C. parvum, C. hominis, or another species is recommended.
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